Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

News

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Jefferies Downgrades Applied Molecular to Hold

By Benzinga Newsdesk
July 7, 5:09 AM
Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.

AMTI

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Mizuho Initiates Coverage On Cerevel Therapeutics Hldg with Neutral Rating, Announces Price Target of $30

By Benzinga Newsdesk
July 7, 5:08 AM
Mizuho analyst Graig Suvannavejh initiates coverage on Cerevel Therapeutics Hldg (NASDAQ:CERE) with a Neutral rating and announces Price Target of $30.

CERE

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Mizuho Initiates Coverage On Harmony Biosciences with Buy Rating, Announces Price Target of $64

By Benzinga Newsdesk
July 7, 5:06 AM
Mizuho analyst Graig Suvannavejh initiates coverage on Harmony Biosciences (NASDAQ:HRMY) with a Buy rating and announces Price Target of $64.

HRMY

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Jefferies Upgrades Tenaris to Buy, Raises Price Target to $46

By Benzinga Newsdesk
July 7, 5:02 AM
Jefferies analyst Alan Spence upgrades Tenaris (NYSE:TS) from Hold to Buy and raises the price target from $35.7 to $46.

TS

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Mizuho Downgrades CytomX Therapeutics to Neutral, Lowers Price Target to $4

By Benzinga Newsdesk
July 7, 4:56 AM
Mizuho analyst Mara Goldstein downgrades CytomX Therapeutics (NASDAQ:CTMX) from Buy to Neutral and lowers the price target from $16 to $4.

CTMX

Read More
1 minute read
  • Eurozone
  • General
  • Markets
  • News
  • Politics

British Prime Minister Boris Johnson Will Resign, According to Officials

By Charles Gross
July 7, 4:54 AM
-Wall Street Journal

EWU

Read More
1 minute read
  • M&A
  • News

Cisco in Talks to Buy India’s Airtel-Vi JV FireFly Networks for 2B Rupees

By Charles Gross
July 7, 4:49 AM
-Economic Times https://economictimes.indiatimes.com/industry/telecom/telecom-news/cisco-in-talks-to-buy-airtel-vi-jv-firefly-networks-for-rs-200-crore/articleshow/92709424.cms

CSCO

Read More
5 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Coinbase, Moderna And 56 Biggest Movers From Yesterday

By Lisa Levin
July 7, 4:42 AM
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.

AHG

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Helen of Troy, Bed Bath & Beyond And 3 Stocks To Watch Heading Into Thursday

By Lisa Levin
July 7, 4:16 AM
With the US stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

BBBY

Read More
2 minute read
  • General
  • Legal
  • Media
  • News
  • Politics

Donald Trump Could Be Subpoenaed With Associates For 2020 Election Interference: Fulton County DA

By Shivdeep Dhaliwal
July 7, 4:02 AM
Former President Donald Trump and his associates could be subpoenaed before a grand jury looking into interference with the outcome of the 2020 Presidential Election in Georgia.

SPY

Posts pagination

Previous 1 … 13,492 13,493 13,494 … 13,551 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service